newsfilter
← Latest News
PR Newswire·

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...